Muraglitazar
CAS: 331741-94-7
Ref. TM-T21587
1mg | 272.00 € | ||
5mg | 668.00 € | ||
10mg | 920.00 € | ||
25mg | 1,388.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,564.00 € |
Product Information
- Pargluva
- BMS-298585
- Bms-298585
- Glycine, N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]-
- N-(4-Methoxyphenoxycarbonyl)-N-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]benzyl]glycine
- N-[(4-Methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine
- N-[(4-methoxyphenoxy)carbonyl]-N-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}glycine
Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia.
Chemical properties
Technical inquiry about: TM-T21587 Muraglitazar
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.